Form 4 for RNXT RenovoRx, Inc.
Accepted 2022-06-17 00:00:00 ET · period of report 2021-08-30 · accession 0001493152-22-017155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-17 | 2021-08-30 | RNXT | Agah Ramtin | Chief Medical Off, Dir, 10% | C - Cnv Deriv | — | +1,295 | 976.3K | +0.1% | — |
| DM | 2022-06-17 | 2021-08-30 | RNXT | Agah Ramtin | Chief Medical Off, Dir, 10% | C - Cnv Deriv | $0.00 | 0 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | C | A | 1,295 | — | 976,295 | D | — | — | (F1) Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. |
| 2 | Derivative | Warrants (right to buy) | 2021-08-30 | C | A | 1,295 | $0.00 | 1,295 | D | $10.80 · — to 2026-08-30 | 1,295 Common Stock | (F2) The shares of Common Stock underlying the warrant are immediately exercisable. |
| 3 | Derivative | Convertible Notes | 2021-08-30 | C | D | 1,295 | $0.00 | 0 | D | — · — to — | 1,295 Common Stock | (F1) Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. |